ITNS Stock | News | Quote | Stock Forum | Tuesday, March 18,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 18, 2014 at 1:20 AM

$ITNS ITonis, Inc. ITNS Company Overview

ITonis, Inc. ITNS Current Price and Quotes
Last Price 0.0117
Previous Close 0.0064 Open 0.0074
Daily Range 0.0125 - 0.0055 52wk Range 0.011 - 0.0015
Volume 47,253,590 Dividend N/A
Average Vol (3m) 8,912,993 Yield N/A

ITNS Stock Message Board http://investorshangout.com/search?q=ITNS&...mp;yt1=Go!

Last Updated: Tuesday, March 18, 2014 00:20:16 AM

ITonis, Inc. ITNS
Company Information

22951 Mill Creek Drive
Suite A-1
Laguna Hills, CA 92653

Website: http://www.itonisholdings.com
Phone: 949-200-8887
Email: mark@itonisholdings.com

ITonis, Inc. ITNS
ITonis, Inc. ITNS
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 27, 2011
Audited Financials Unaudited
Latest Report Nov 30, 2013 Annual Report
CIK 0001360184
Fiscal Year End 11/30
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 8999 - Services, misc
Business Status Development Stage Company a/o Nov 10, 2010
Incorporated In: NV, USA
Year of Inc. 2005
Employees 3 a/o May 02, 2011
Company Officers/Contacts

Mark Cheung CEO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Berg & Co.
50 Francisco Street
Suite 120
San Francisco, CA, 94133
United States

Legal Counsel
Michael Berg
16810 Ave of the Fountains
Fountain Hills, AZ, 85268
United States

Naccarato and Associates
1100 Quail Street
Newport Beach, CA, 92660
United States

Investor Relations Firm
Not Available

ITonis, Inc. ITNS
ITNS Security Details

Share Structure

Market Value1 $9,968,917 a/o Mar 17, 2014
Shares Outstanding 852,044,186 a/o Aug 31, 2013
Float 154,828,864 a/o May 31, 2013
Authorized Shares 1,000,000,000 a/o Aug 31, 2013
Par Value 0.001
Shareholders

Shareholders of Record 662 a/o May 31, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Mar 21, 2007 Mar 19, 2007 Mar 20, 2007
Security Notes

Capital Change=shs increased by 3 for 1 split. Ex-date=03/21/2007. Rec date=03/19/2007. Pay date=03/20/2007.
Short Selling Data

Short Interest 0 (-100%)
Feb 28, 2014
Significant Failures to Deliver No
Transfer Agent(s)

Action Stock Transfer Corporation

ITonis, Inc. ITNS Financials
Period Ending Nov 30, 2013 Nov 30, 2012
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses

Research and Development - -
Sales, General and Admin. 1,009 3,193
Non-Recurring Items 16 2,093
Other - -
Operating Income (1,025) (5,286)
Income From Continuing Operations

Add'l Income/Expense Items 259 958
Earnings Before Interest and Tax (766) (4,328)
Interest Expense 6 -
Earnings Before Tax (772) (4,329)
Income Tax 1 1
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (773) (4,329)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (773) (4,329)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (773) (4,329)

ITonis, Inc. ITNS Recent News

Mar 17, 2014 Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Feb 28, 2014 Itonis Pharmaceuticals Received Emesyl Samples for Evaluation

ITNS ITonis, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ITNS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ITNS/quote
Stock Chart http://www.otcmarkets.com/stock/ITNS/chart
Company Info http://www.otcmarkets.com/stock/ITNS/company-info
Recent News http://www.otcmarkets.com/stock/ITNS/news
Financials http://www.otcmarkets.com/stock/ITNS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ITNS/filings
Short Sales http://www.otcmarkets.com/stock/ITNS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ITNS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ITNS/research
Summary http://finance.yahoo.com/q?s=ITNS
Historical Prices http://finance.yahoo.com/q/hp?s=ITNS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ITNS
Basic Chart http://finance.yahoo.com/q/bc?s=ITNS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ITNS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ITNS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ITNS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ITNS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ITNS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ITNS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ITNS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ITNS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ITNS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ITNS
Balance Sheet http://finance.yahoo.com/q/bs?s=ITNS
Cash Flow http://finance.yahoo.com/q/cf?s=ITNS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ITNS
Market Watch http://www.marketwatch.com/investing/stock/ITNS
Bloomberg http://www.bloomberg.com/quote/ITNS:US
Morningstar http://quotes.morningstar.com/stock/s?t=ITNS
Bussinessweek http://investing.businessweek.com/research/st...icker=ITNS
Barchart http://www.barchart.com/quotes/stocks/ITNS
OTC Short Report http://otcshortreport.com/index.php?index=ITNS
Investopedia http://www.investopedia.com/markets/stocks/ITNS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...